Angelini Ventures
Corporate VCRome · Seed–Growth · 4 people tracked
Investment thesis
Angelini Ventures builds and invests in companies working to transform healthcare. Backed by a €300 million commitment, the firm invests globally in BioTech and HealthTech businesses. Its focus centers on using technology to improve healthcare delivery, reshape the patient journey, and address unmet needs among vulnerable populations.
Source: firm website, verified Aug 3, 2026.
Team · 4 people
from public directories
What they invest in
from 7 of 28 portfolio companiesMedical Devices ×6Biotech ×5Healthtech ×5Digital Health ×3AI & Machine Learning ×1FemTech ×1Wellness & Fitness ×1
HQs:United States×4
Investments · 28 tracked
founders shown can be your intro pathGenialis develops artificial intelligence models trained on ethnically diverse cancer datasets to predict patient responses to targeted therapies and immunotherapies, supporting treatment decisions for pharmaceutical and diagnostic companies.
AI & Machine LearningBiotechMedical DevicesBoston, US
Miha Štajdohar(Executive Officer, Director)Rafael Rosengarten(Chief Executive Officer and Co-founder)Luka Ausec(Executive Officer)Hamzeh Abdul-Hadi(Director)Tjasa Krisper Kutin(Executive Officer)
BoardIta Lu(Director)
Avation Medical manufactures the Vivally System, an FDA-cleared wearable device that uses transcutaneous tibial nerve stimulation to treat overactive bladder and urge urinary incontinence in at-home 30-minute sessions.
Digital HealthHealthtechMedical DevicesValencia, US
Jill Schiaparelli(Executive Officer, Director)Thomas Shehab, MD(Director)Kevin Wasserstein(Director)
Cadence develops a neuromodulation system intended to be a more effective, less invasive treatment for people living with drug-refractory epilepsy.
BiotechDigital HealthHealthtechMedical DevicesSammamish, US
Kent Leyde(Executive Officer, Director, Promoter)Warren Douglas Sheffield(Executive Officer, Director, Promoter)
UK company focused on non-invasive brain measurements
COUR develops targeted therapies for autoimmune diseases using an antigen-specific platform technology designed to restore immune tolerance while preserving normal immune function.
BiotechHealthtechMedical Devices
Damona Pharma develops therapies targeting cognitive deficits by using positive allosteric modulators to restore neural connections and improve brain cell communication.
BiotechHealthtechMedical Devices
Freya Biosciences is a clinical-stage immunology company developing therapies targeting inflammation and immune dysregulation in conditions affecting women, including infertility and pregnancy-related dysbiosis.
BiotechFemTechHealthtech
Noctrix Health develops clinically validated wearable therapeutics for managing chronic neurological disorders, with its first product Nidra receiving FDA De Novo authorization and dedicated CMS HCPCS codes.
Digital HealthMedical DevicesWellness & FitnessPleasanton, US
Italy-based telehealth psychotherapy services
Frequently asked questions
- What stage does Angelini Ventures invest at?
- Angelini Ventures invests at the Seed, Series A, Series B, Series C, Growth stages.
- What sectors does Angelini Ventures focus on?
- Angelini Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices, Mental Health.
- Where is Angelini Ventures located?
- Angelini Ventures is headquartered in Rome, IT.
Media · Podcasts & interviews
featuring the teamElia Stupka, Angelini Ventures
The Health Care Blog's Channel · Elia Stupka
Similar investors
GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.
WELL Health Ventures is the corporate venture arm of WELL Health Technologies, backing digital health companies with an emphasis on modernizing healthcare in Canada.
JAZZ Venture Partners is a venture capital firm investing in companies at the intersection of technology, neuroscience, and human performance, spanning digital health, biosciences, and AI.
Aescuvest is a European healthtech investment firm that sources, structures, and co-invests in healthtech financing rounds through dedicated single-deal SPVs, alongside business angels, family offices, and corporate partners.